0000000000455703
AUTHOR
G. Bartsch
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy
BACKGROUND: Immediate initiation of antiretroviral therapy (ART) regardless of CD4 cell count reduces risk for AIDS and non-AIDS-related events in asymptomatic, HIV-positive persons and is the standard of care. However, most HIV-positive persons initiate ART when their CD4 count decreases below 500 × 10 9 cells/L. Consequences of delayed ART on risk for non-AIDS-defining and AIDS-defining cancer, one of the most common reasons for death in HIV, are unclear. OBJECTIVE: To estimate the long-term risk difference for cancer with the immediate ART strategy.DESIGN: Multinational prospective cohort study.SETTING: The D:A:D (Data collection on Adverse events of anti-HIV Drugs) study, which included…
Postersitzung 13: Inkontinenz — Harnabflußstörungen
Den guten Fruhresultaten von 80–90% stehen masige Langzeiterfolgsquoten von 50–70% nach 5 Jahren bei den bekannten urethralen Suspensionsmethoden entgegen. Aus der Schlusfolgerung, das primar befriedigende funktionelle Verhaltnisse vorliegen, ergibt sich der Ansatz, durch Optimierung bereits bestehender Verfahren bessere Langzeitergebnisse anzustreben.